228 related articles for article (PubMed ID: 37485204)
1. Primary Ovarian Non-Hodgkin's Lymphoma: An 18-year Retrospective Institutional Study and Review of Literature from India.
Rajendran T; Kini JR; Prasad K
Cureus; 2023 Jun; 15(6):e40685. PubMed ID: 37485204
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. [NON-HODGKIN'S LYMPHOMA OF THE FEMALE GENITAL SYSTEM--A LITERATURE REVIEW].
Ganovska A; Kovachev S
Akush Ginekol (Sofiia); 2015; 54(3):17-23. PubMed ID: 26137775
[TBL] [Abstract][Full Text] [Related]
5. Primary extranodal non-Hodgkin's lymphoma of oral cavity--a single centre retrospective study.
Sirsath NT; Lakshmaiah KC; Das U; Lokanatha D; Chennagiri SP; Ramarao C
J Cancer Res Ther; 2014; 10(4):945-50. PubMed ID: 25579534
[TBL] [Abstract][Full Text] [Related]
6. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
Itoh K; Ohtsu T; Fukuda H; Sasaki Y; Ogura M; Morishima Y; Chou T; Aikawa K; Uike N; Mizorogi F; Ohno T; Ikeda S; Sai T; Taniwaki M; Kawano F; Niimi M; Hotta T; Shimoyama M; Tobinai K;
Ann Oncol; 2002 Sep; 13(9):1347-55. PubMed ID: 12196359
[TBL] [Abstract][Full Text] [Related]
9. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
[TBL] [Abstract][Full Text] [Related]
10. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
Naresh KN; Srinivas V; Soman CS
Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
12. Primary renal non-Hodgkin's lymphoma. An unusual extranodal site.
Okuno SH; Hoyer JD; Ristow K; Witzig TE
Cancer; 1995 May; 75(9):2258-61. PubMed ID: 7712433
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
14. Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non-Hodgkin's lymphomas, according to data in the population-based registry of the Comprehensive Cancer Centre West.
Krol AD; Hermans J; Dawson L; Snijder S; Wijermans PW; Kluin-Nelemans HC; Kluin PM; van Krieken JH; Noordijk EM
Cancer; 1998 Oct; 83(8):1612-9. PubMed ID: 9781956
[TBL] [Abstract][Full Text] [Related]
15. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
[TBL] [Abstract][Full Text] [Related]
16. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists.
Naresh KN; Agarwal B; Nathwani BN; Diebold J; McLennan KA; Muller-Hermelink KH; Armitage JO; Weisenburger DD
Leuk Lymphoma; 2004 Aug; 45(8):1569-77. PubMed ID: 15370208
[TBL] [Abstract][Full Text] [Related]
17. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
Shi Y; Zhou P; Han X; He X; Zhou S; Liu P; Yang J; Zhang C; Gui L; Qin Y; Yang S; Zhao L; Yao J; Zhang S
Chin J Cancer; 2015 Sep; 34(11):522-30. PubMed ID: 26370464
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience.
Yun J; Kim SJ; Kim JA; Kong JH; Lee SH; Kim K; Ko YH; Kim WS
Acta Haematol; 2010; 123(1):48-54. PubMed ID: 19955711
[TBL] [Abstract][Full Text] [Related]
19. Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas.
Armitage JO
Clin Lymphoma; 2002 Dec; 3 Suppl 1():S5-11. PubMed ID: 12521383
[TBL] [Abstract][Full Text] [Related]
20. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
